日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity

开发具有体内抗关节炎活性的四氢吲哚基 HDAC6 抑制剂

Hyun-Mo Yang, Changsik Lee, Jaeki Min, Nina Ha, Daekwon Bae, Gibeom Nam, Hyun-Ju Park

Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia

蛋白水解靶向 LCK 作为 T 细胞急性淋巴细胞白血病治疗方法的临床前评估

Jianzhong Hu, Jamie Jarusiewicz, Guoqing Du, Gisele Nishiguchi, Satoshi Yoshimura, John C Panetta, Zhenhua Li, Jaeki Min, Lei Yang, Divyabharathi Chepyala, Marisa Actis, Noemi Reyes, Brandon Smart, Ching-Hon Pui, David T Teachey, Zoran Rankovic, Jun J Yang

Ca2+-mediated mitochondrial inner membrane permeabilization induces cell death independently of Bax and Bak

Ca2+介导的线粒体内膜通透性增加可诱导细胞死亡,且该过程独立于Bax和Bak蛋白。

Giovanni Quarato ,Fabien Llambi ,Cliff S Guy ,Jaeki Min ,Marisa Actis ,Huan Sun ,Shilpa Narina ,Shondra M Pruett-Miller ,Junmin Peng ,Zoran Rankovic ,Douglas R Green

Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACs

开发有效且选择性的 Janus Kinase 2/3 指导 PG-PROTAC

Lisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, Marisa Actis, Stanley Nithianantham, Anand Mayasundari, Jaeki Min, Dylan Maxwell, Jeremy Hunt, Brandon Smart, Jun J Yang, Gisele Nishiguchi, Marcus Fischer, Charles G Mullighan, Zoran Rankovic

Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia

CRLF2 重排急性淋巴细胞白血病中 Janus 激酶的降解

Yunchao Chang, Jaeki Min, Jamie A Jarusiewicz, Marisa Actis, Shanshan Yu-Chen Bradford, Anand Mayasundari, Lei Yang, Divyabharathi Chepyala, Lisa J Alcock, Kathryn G Roberts, Stanley Nithianantham, Dylan Maxwell, Lauren Rowland, Randolph Larsen, Aman Seth, Hiroaki Goto, Toshihiko Imamura, Koshi Akah

Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators

从聚焦的 Cereblon 调节剂库中鉴定高效、选择性强且口服生物利用度高的小分子 GSPT1/2 降解剂

Gisele Nishiguchi,Fatemeh Keramatnia,Jaeki Min,Yunchao Chang,Barbara Jonchere,Sourav Das,Marisa Actis,Jeanine Price,Divyabharathi Chepyala,Brandon Young,Kevin McGowan,P Jake Slavish,Anand Mayasundari,Jamie A Jarusiewicz,Lei Yang,Yong Li,Xiang Fu,Shalandus H Garrett,James B Papizan,Kiran Kodali,Junmin Peng,Shondra M Pruett Miller,Martine F Roussel,Charles Mullighan,Marcus Fischer,Zoran Rankovic

AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss

AZD5438-PROTAC:一种选择性 CDK2 降解剂,可预防顺铂和噪声引起的听力损失

Santanu Hati, Marisa Zallocchi, Robert Hazlitt, Yuju Li, Sarath Vijayakumar, Jaeki Min, Zoran Rankovic, Sándor Lovas, Jian Zuo

Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

苯基戊二酰亚胺:用于 PROTAC 设计的替代 Cereblon 粘合剂

Jaeki Min, Anand Mayasundari, Fatemeh Keramatnia, Barbara Jonchere, Seung Wook Yang, Jamie Jarusiewicz, Marisa Actis, Sourav Das, Brandon Young, Jake Slavish, Lei Yang, Yong Li, Xiang Fu, Shalandus H Garrett, Mi-Kyung Yun, Zhenmei Li, Stanley Nithianantham, Sergio Chai, Taosheng Chen, Anang Shelat, 

Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases

致癌 MAGE 泛素连接酶的底物识别和化学抑制的结构基础

Seung Wook Yang #, Xin Huang #, Wenwei Lin, Jaeki Min, Darcie J Miller, Anand Mayasundari, Patrick Rodrigues, Elizabeth C Griffith, Clifford T Gee, Lei Li, Wei Li, Richard E Lee, Zoran Rankovic, Taosheng Chen, Patrick Ryan Potts

BRAF inhibition protects against hearing loss in mice

BRAF抑制剂可保护小鼠免受听力损失。

Matthew A Ingersoll ,Emma A Malloy ,Lauryn E Caster ,Eva M Holland ,Zhenhang Xu ,Marisa Zallocchi ,Duane Currier ,Huizhan Liu ,David Z Z He ,Jaeki Min ,Taosheng Chen ,Jian Zuo ,Tal Teitz